US regulators probing cardio risks in testosterone products

February 1, 2014

US federal regulators said Friday they were investigating products containing testosterone after recent studies suggested a higher risk of strokes and heart attacks in men being treated with the hormone.

The Food and Drug Administration stressed, however, that it has "not concluded that FDA-approved testosterone treatment increases the risk of stroke, or death."

"FDA is providing this alert while it continues to evaluate the information from these studies and other available data," it said in a safety alert, referring to two related studies.

Patients undergoing should not stop their treatment without consulting their physician first, the FDA recommended.

Health care professionals were also asked to consider whether the benefits of FDA-approved testosterone treatment were likely to outweigh the possible risk of treatment.

The announcement followed publication of a study on Wednesday by the PLOS ONE science journal suggesting that men aged 65 and older being treated with testosterone were twice as likely to suffer heart attacks in the month after they began treatment.

The study, which analyzed findings from 56,000 men in the United States between 2008 and 2010, also revealed a sharply increased risk among younger men with a history of heart disease.

In November, a separate clinical study in the Journal of the American Medical Association reported that older men using testosterone, including many with a history of heart problems, faced a 30 percent greater chance of mortality, heart attack or cardiovascular event.

A US government-funded study to determine whether men using to build muscle and increase strength was halted in 2009 after the high rate of cardiovascular problems related to the treatment.

Explore further: Low testosterone may be linked to heart problems

Related Stories

Low testosterone may be linked to heart problems

September 24, 2013

Men who have low testosterone levels may have a slightly elevated risk of developing or dying from heart disease, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology ...

Excessive testosterone raises mortality risk in older men

November 20, 2013

Older men whose testosterone levels were neither low nor high tended to live longer, according to new research accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

Midrange testosterone levels better for older men

January 10, 2014

(Medical Xpress)—Optimal levels of testosterone - meaning neither low nor high - in older men are associated with better survival, according to a study recently published by a team of UWA researchers in the Journal of Clinical ...

Recommended for you

No new heart muscle cells in mice after the newborn period

November 5, 2015

A new study from Sweden's Karolinska Institutet shows that new heart muscle cells in mice are mainly formed directly after birth. After the neonatal period the number of heart muscle cells does not change, and A new study ...

Nanotechnology could spur new heart treatment

October 29, 2015

A new nanoparticle developed by University of Michigan researchers could be the key to a targeted therapy for cardiac arrhythmia, a condition that causes the heart to beat erratically and can lead to heart attack and stroke.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.